VistaGen Therapeutics

3 followers

‌

VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Education, Pharmaceutical

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Shawn K. Singh

CEO & Director

Shawn K. Singh

Collapse

Reid Adler

Chief Legal Officer

Cindy Anderson

CFO

Jessica R. Haskell

VP, Associate General Counsel & Secretary

Mark J. Ginski

SVP, Head of CMC

Allen Cato III

SVP, Development Operations

Trisha Fitzmaurice

SVP, Human Resources

Joshua Prince

VP, Strategic Insights & Analytics

Greg Weilersbacher

VP, Quality Assurance

Louis Monti

VP, Translational Medicine

Ross A. Baker

VP, Global Medical Affairs

Mark Flather

VP, Investor Relations

Mark A. McPartland

VP, Corporate Development

Ester Salmán

VP, Clinical Research

Imogene Dunn

VP, Biostatistics

Michelle Peters Wellington

VP, Communications

Margie Schneider

Director, Clinical Supply Chain

Teams

Leadership Team

5 members

Clinical and Medical Team

6 members

Legal and Compliance

3 members

Project Management

3 members

Regulatory and Quality Affairs

3 members

Similar companies

Lenz Therapeutics

3 followers

Springboard Collaborative

143 followers

Pearson

59 followers

McGraw-Hill

24 followers

Organon

15 followers

brightwheel

11 followers

Apellis Pharmaceuticals

8 followers

New Globe Utopia (∆∞Ο)®

14 followers

Texas A&M University – Corpus Christi

5 followers

AbbVie

176 followers

SmithRx

4 followers

Explore companies